Scancell Share Discussion Threads

[the real lozan] 30/6/2017 17:08

Hello 'Raindrop'

[wigwammer] 30/6/2017 17:06

"STILL, as yet, NO SIGN of the VITAL FUNDING being resolved."I suspect a rising share price goes some way to resolving the funding issue.

[wanderer1210_0] 30/6/2017 16:49

Looking at the Oxford Dictionary, the definition of "Terror" under the informal meaning is more apt to you Dr Melanoma "Informal.a person or thing that is especially annoying or unpleasant."

[the real lozan] 30/6/2017 16:44

So, following a 'quite abnormal' week - S P wise, *WE* now enter the second half of 2017... with an S P that still NEEDS to rise circa 17% just to get back to the level it started 2017 at.
AND
STILL, as yet, NO SIGN of the VITAL FUNDING being resolved.

[j777j] 30/6/2017 16:24

Promotion glorification etc.Expect a visit in the night

[terror] 30/6/2017 16:21

J7

A poorly paid clown is still a happy clown

The Club are unhappy with an average of 46p.

The astute never joined the club and as a result we are not drowning......enjoy the re-flotation before someone comes around and bursts your rubber rings.

[tosh123] 30/6/2017 15:14

See you in October.

[j777j] 30/6/2017 14:57

I do know.You are nothing but a clown a poorly paid clown.

[tosh123] 30/6/2017 14:50

J777J.... honestly, you really should be on the stage.
As for knowing about business, if only you knew !
Meanwhile the share price is up 25% ???? Yes it is, Its up 25% from a 6 year low !!!!
so the current share price is about 60% down from what it was about 2 years ago, and about 80% down from where it was about 4 years ago.... Not a great performance in anyone's book.

You're an idiot and i wait to meet you back here in October complete with your £1 / share... hahaha

[j777j] 30/6/2017 14:47

What kind of scum would use terror as a bb name?I suggest you read up the draconian UK anti terror laws.The promotion,distribution etc

[terror] 30/6/2017 14:40

J777J

Terror = nothing to do with recent events but merely a football nickname.

Suggest you tone down your posts or you will get as bad as the folks on here.


LOL

[tosh123] 30/6/2017 14:33

J777J
OK, so lets meet back here in lets say, October, by which time , according to you, there would have been a trade sale at at least £1 / share.
Im going to suggest that in October, far from having a trade sale at a price north of £1, that there will have been no sale, and that we will have had further dilution due to another fund raising event, and the share price will probably be back into single figures.

[j777j] 30/6/2017 14:29

What kind of gutter scum comes on the boards with a name like terror? Utter scum.

[terror] 30/6/2017 14:08

Panmure Gordon

Wed, 18th May 2016 - 12:30
Panmure Gordon today reaffirms its buy investment rating on Scancell Holdings PLC (LON:SCLP) and cut its price target to 68p (from 79p​).

10p placing
Panmure Gordon (UK) Limited ("Panmure Gordon") is acting as Financial Adviser, Nominated Adviser and sole Bookrunner to the Company in relation to the Placing.

LOL

PG=LIES

[mikethebike4] 30/6/2017 13:47

j7
How many times have we heard all this before ?
Mtb4

[j777j] 30/6/2017 13:20

Remember this just a few months ago....."Panmure Gordon analyst Mike Mitchell, in a note to clients, said Scancell is poised for a "significant" year."Immunotherapy as a field continues to generate ever-more-prominent headlines and we view Scancell as a seriously overlooked player in this area," he added."

[j777j] 30/6/2017 13:14

You will note.all Chiplin's companies were either acquired IPO ed Scancell is next.

[j777j] 30/6/2017 13:11

This has been the game.plan for a while and I suspect the global patent will now expedite the trade sale.They brought in a heavyweight US industry pro in order to break into the USA.Dr John Chiplin, who is based in the US and is currently Scancell's Non-Executive Chairman, will assume the role of Executive Chairman. John will be directly involved in raising the corporate profile of the Company in the US. Recent US transaction experience, as a director/CEO, includes Benitec Biopharma (US IPO), Medistem (acquired by Intrexon), Arana (acquired by Cephalon) and Domantis (acquired by GSK). Prior to Scancell John was CEO of Polynoma, a Phase III cancer vaccine company, based in San Diego.

[the real lozan] 30/6/2017 13:04

Re 9755
What folks see here is Suntans's 'good side', overjoyed with the rise in S P, that has the effect of 'lifting' him from 'sitting on HUGE LOSSES'... to now, merely 'sitting on BIG LOSSES'
With the FUNDING question STILL to be resolved.
Don't see how ANYONE could be " disappointed ... but following recent good news the share price continues to rise." with that out-look.
*WE* must hope the 'fun BUYers' are not being 'set-up' for a shock ???

[j777j] 30/6/2017 13:01

I expect this to have a trade sale within a few months.Without global patent protection there is little value.With global patent protection,this is a viable and valuable business.100p a share my takeover price target.

[gazza] 30/6/2017 12:51

10 bagger in two years - seems like a good return to me.

[tosh123] 30/6/2017 12:46

J777J.... Hahaha .. You should be on the stage !
havn't you forgotten a little something ? The matter of an insignificant £22 mill or so.
You havn't been talking to that inbred ineptico have you ?

This may well make £1 +, but you wont be seeing anything like that lofty figure for a couple of years yet.